Medical treatments for male and female pattern hair loss

被引:194
作者
Rogers, Nicole E.
Avram, Marc R.
机构
关键词
D O I
10.1016/j.jaad.2008.07.001
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Male and female pattern hair loss affects a large percentage of the population, and patients frequently present for treatment of this to their dermatologist. Here we review the many treatments available for hair loss. We review the evidence for each, and outline the most effective treatment strategies for both men and women. Learning objective: At the conclusion of this article, the reader should be able to describe the most effective treatments for hair loss, understand their mechanism(s) of action, and explain which treatments are the best in different settings.
引用
收藏
页码:547 / 566
页数:20
相关论文
共 189 条
[2]
Low-level laser therapy enhances wound healing in diabetic rats: A comparison of different lasers [J].
Al-Watban, Farouk A. H. ;
Zhang, Xing Yang ;
Andres, Bernard L. .
PHOTOMEDICINE AND LASER SURGERY, 2007, 25 (02) :72-77
[3]
ALLERGIC CONTACT-DERMATITIS FROM MINOXIDIL [J].
ALOMAR, A ;
SMANDIA, JA .
CONTACT DERMATITIS, 1988, 18 (01) :51-52
[4]
Depression circumstantially related to the administration of finasteride for androgenetic alopecia [J].
Altomare, G ;
Capella, GL .
JOURNAL OF DERMATOLOGY, 2002, 29 (10) :665-669
[5]
The effect of 5α reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men [J].
Amory, John K. ;
Wang, Christina ;
Swerdloff, Ronald S. ;
Anawalt, Bradley D. ;
Matsumoto, Alvin M. ;
Bremner, William J. ;
Walker, Susan E. ;
Haberer, Lynda J. ;
Clark, Richard V. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (05) :1659-1665
[6]
Chemoprevention of prostate cancer in men at high risk: Rationale and design of the reduction by dutasteride of prostate cancer events (reduce) trial [J].
Andriole, G ;
Bostwick, D ;
Brawley, O ;
Gomella, L ;
Tindall, D ;
Breed, S ;
Somerville, M ;
Rittmaster, R .
JOURNAL OF UROLOGY, 2004, 172 (04) :1314-1317
[7]
High-grade prostate cancer in the prostate cancer prevention trial: Fact or artifact? [J].
Andriole, Gerald L. ;
Humphrey, Peter A. ;
Serfling, Robert J. ;
Grubb, Robert L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (18) :1355-1356
[8]
Andriole GL, 2004, UROLOGY, V64, P537, DOI 10.1016/j.urology.2004.04.084
[9]
Effect of the dual 5α-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer [J].
Andriole, GL ;
Humphrey, P ;
Ray, P ;
Gleave, ME ;
Trachtenberg, J ;
Thomas, LN ;
Lazier, CB ;
Rittmaster, RS .
JOURNAL OF UROLOGY, 2004, 172 (03) :915-919
[10]
Safety and tolerability of the dual 5α-reductase inhibitor dutasteride in the treatment of benign prostatic hyperplasia [J].
Andriole, GL ;
Kirby, R .
EUROPEAN UROLOGY, 2003, 44 (01) :82-88